Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-30
2011-08-30
Seaman, D M (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S314000
Reexamination Certificate
active
08008501
ABSTRACT:
The present invention provides quinoline compounds that inhibit the IgE receptor signaling cascade that leads to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE receptor signaling cascade.
REFERENCES:
patent: 4087535 (1978-05-01), Heubach
patent: 4829072 (1989-05-01), Hamprecht et al.
patent: 0 098 486 (1984-01-01), None
patent: 11-189586 (1999-07-01), None
patent: WO 94/24095 (1994-10-01), None
deWeck, abstract only of CA 142:480237, abstract of J of Invest allerg and Clin Immunol, vol. 14(4), pp. 253-273, 2004.
Anthony R. West, Solid State Chemistry and its Application, Wiley, New York, 1988, pp. 358 &365.
English translation of Anthony R West, Solid State Chemistry and its Application, Wiley, New York, 1988, pp. 358 & 365.
West, Anthony R., “Solid State Chemistry and its Application”, Wiley, New York, 1988, pp. 358 and 365.
Display for Chemcats, Chemical Library, Answer 1, “4-Isoxazolecarobxylic acid, 5-methyl-3-phenyl-, 6-fluoro-2-methyl-4-quinolinyl ester”, © 2004 ACS on STN, CAS Registry No. 216774-15-1,Order No. BTB 01297 (1 pg.), Supplier: Ambinter.
Display for Chemcats, Chemical Library, Answer 2, “6-fluoro-2-methyl-4-quinolyl 5-methyl-3-phenylisoxazole-4-carboxylate”, © 2004 ACS on STN, CAS Registry No. 216774-15-1,Order No. BTB 01297 (2 pgs.), Supplier: Maybridge plc.
Li Hui
Singh Rajinder
McDonnell Boehnen & Hulbert & Berghoff LLP
Rigel Pharmaceuticals Inc.
Seaman D M
Young Travis
LandOfFree
Quinoline compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623090